INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo HEXAL GEMCITABINE 200mg IVI (infusion)

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
S4

PROPRIETARY NAME
(and dosage form):

HEXAL GEMCITABINE 200mg IVI (infusion)

COMPOSITION:
Each vial contains gemcitabine hydrochloride equivalent to
gemcitabine 200,0 mg

ATC CLASSIFICATION:
L01BC05

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
41/28/0490

APPLICANT:
HEXAL PHARMA (SA) (PTY) LTD

MANUFACTURER:
SANDOZ SA, BUENOS AIRES, ARGENTINA

AVAILABILITY:
Please check with company.

DATE OF REGISTRATION:
9 October 2009

SOURCE:
20091209 - National Gazette No 32774 of 09-Dec-2009, Volume 534, 032

Date posted: July 2014

LINKS:
eMC
: (more than one available)
Summary of Product Characteristics
http://www.medicines.org.uk/emc/medicine/27136
The Patient Information Leaflet (PIL)
http://www.medicines.org.uk/emc/medicine/27128

NHS choices:
http://www.nhs.uk/medicine-guides/pages/selectorshow.aspx?medicine=Gemcitabine%20hydrochloride

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014